Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
You are on the lowest starting dose, which is intentionally subtherapeutic for weight loss
At the maximum 15mg dose, average weight loss reached 22.5%
There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved
Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W
Kirk Habegger, a University of Alabama at Birmingham professor of endocrinology, diabetes and metabolism, said he is unaware of any terminal illnesses that could be treated specifically with glucagon receptor activation
US$ 24.00
US$ 24.79
US$ 26.04
US$ 29.37
